Exercise-induced Bronchoconstriction
📧 Sign up to get email alerts when something new happens for Exercise-induced Bronchoconstriction.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-06-23FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.)
FDA approved a supplemental application for ALBUTEROL SULFATE from Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. under an ANDA for a generic p…
-
FDA approval · 2023-06-07FDA Approved: MONTELUKAST — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Montelukast submitted by BluePoint Laboratories.
-
FDA approval · 2022-01-19FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Montelukast (generic, Sandoz Inc), updating the product's approval status under the ANDA. Montel…
-
FDA approval · 2022-01-19FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast sodium from Rising Pharma Holdings, Inc., enabling changes to its labeling or indica…
-
FDA approval · 2022-01-19FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast Sodium from Rising Pharma Holdings, Inc., updating the labeling under an existing ap…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-10-28FDA Approved: ALBUTEROL SULFATE — Supplemental Application (American Health Packaging)
FDA approved a supplemental application for albuterol sulfate, a generic inhalation drug, submitted by American Health Packaging.
-
FDA approval · 2021-10-15FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Torrent Pharmaceuticals Limited's Montelukast Sodium under ANDA 201515, clearing regulatory appr…
-
FDA approval · 2021-10-15FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for Montelukast Sodium from Torrent Pharmaceuticals Limited under an approved ANDA. This action …
-
FDA approval · 2021-07-30FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Aurobindo Pharma Limited to market Montelukast sodium as a generic product.
-
CLINICAL_TRIALS trial_result · 2021-07-21Clinical Trial Update: Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity [Phase 4]
Phase 4 trial on reducing exercise-induced bronchoconstriction in children with asthma and obesity was terminated; results posted in 2021.
-
FDA label_change · 2021-02-22FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) filed by Organon LLC, resulting in changes to the product lab…
-
FDA approval · 2021-01-29FDA Approved: MONTELUKAST — Supplemental Application (XLCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Montelukast from XLCare Pharmaceuticals Inc., approving changes to the generic product under…
-
FDA approval · 2021-01-25FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare Inc.'s montelukast sodium product under ANDA 202717.
-
FDA approval · 2020-11-10FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for montelukast sodium from Dr. Reddy's Laboratories Limited, under an ANDA.
-
FDA approval · 2020-11-10FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium from Dr. Reddy's Laboratories Limited, granting continued approval of a gener…
-
FDA approval · 2020-10-20FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for Montelukast Sodium, marking approval of a generic montelukast product und…
-
FDA approval · 2020-10-20FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for Montelukast Sodium (ANDA 203432) from Ajanta Pharma USA Inc., granting approval of this generic …
-
FDA approval · 2020-10-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Montelukast Sodium by Torrent Pharmaceuticals Limited (ANDA 201515).
-
FDA approval · 2020-10-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's supplemental application for montelukast sodium, authorizing the regulatory action for th…
-
FDA approval · 2020-09-04FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application from Sandoz Inc for montelukast under the ANDA, confirming changes to the generic product's labeling…
-
FDA approval · 2020-09-04FDA Approved: MONTELUKAST SODIUM — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' Montelukast Sodium as a generic version of montelukast for the prevention and maintenance treatment of …
-
FDA approval · 2020-08-14FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Montelukast Sodium from Rising Pharma Holdings, Inc. This action authorizes changes to the p…
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes [Phase 4]
Phase 4 trial assessing the effectiveness of ipratropium bromide in preventing exercise-induced bronchoconstriction in athletes; study compl…
-
FDA approval · 2020-02-18FDA Approved: MONTELUKAST SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for Montelukast Sodium, a generic montelukast product.
-
FDA approval · 2019-11-08FDA Approved: MONTELUKAST — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Montelukast submitted by BluePoint Laboratories. The action pertains to an additional indication…